SMCI earnings
What we are looking for: Company-reported facts that test this holding's written memo.
Why this matters: SMCI is ~20% direct book weight — the report is a test of that stake, not a generic headline.
As of Aug 5, 2026 · 5 holdings
You're a growth-tilted book — mostly large tech — and one shared thread touches about 50% of your money — enough to feel, not enough to be the whole book.
Hyperscaler capex is really one bet. 50% of your risk loads on NVDA, MSFT — they tend to move together.
You hold 5 line items across your book — mostly large tech.
Direct holdings: NVDA (35%), SMCI (20%), INTC (15%), ARM (15%), MSFT (15%).
Speculation
62%
$37,102
Fundamentals
17%
$10,100
Growth
21%
$12,798
By holding
By sector
Holdings scan
You're a growth-tilted book — mostly large tech — and one shared thread touches about 50% of your money — enough to feel, not enough to be the whole book.
Hyperscaler capex is really one bet. 50% of your risk loads on NVDA, MSFT — they tend to move together.
Under the surface you have about 4.3 effective bets across 1 shared reason. The largest sleeve is "Tech / Growth".
Grouped by what would actually hurt them, the largest threads are Tech / Growth (~100% of the book). Few bets, and concentrated — one theme moves most of your book.
Vs SPY (composition)
Your book concentrates roughly 50% in Hyperscaler capex. A typical broad index spreads risk across many themes — we are not showing a precise SPY figure until reference stats publish nightly.
| Measure | Your book |
|---|---|
| Top theme concentration | 50% |
| Speculation share | 62% |
SPY comparison is qualitative until WP-6 reference stats land — no invented index percentages.
Add buy dates to see how this book has actually run vs SPY
Upload purchase dates and average cost on confirm — the same input unlocks the Where you stand section and performance vs the index.
What would hurt more than one name at once runs through Technology — that's the thread tying the book together.
That sentence would touch about $60,000 of the book.
Grouped by sector for now — no specific thesis-breaker on file yet for the shared thread.
On a bad day, pain won't hit every holding the same way or on the same clock — watch who moves first.
This book can swing hard — mostly because so much of the price is speculation, not because every day is calm.
A normal day moves your book about $1.4k either way. A rough stretch historically has meant around a 11% drawdown for a book with your factor tilt — not a crash, just a hard month. The whole thing swings about 1.7× as much as Nasdaq. About 62% of your book's price is speculation — the rest is earnings and expected growth.
So a red day here is normal weather, not a reason to panic.
Upside here is only what the companies have actually said — no invented targets.
Guidance not yet on file for these holdings — company-stated forward lines will show here when we have them.
Coming up: SMCI (2026-08-11). These are the dates your theses get tested — not generic headlines.
We don't have average cost or buy dates for this book yet.
The risk you have no offset for
The checkup stops where advice would begin. What remains is yours to write into the memos and live with.
Write the memo for your largest positions. Pre-register what you will do if a name falls hard with no falsifier fired — and what you will do if one fires. Those contract verbs live in your memos until you decide otherwise.
No buy/sell language here. Chat can stress the book when you ask.